Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Formative Research

Date Submitted: Oct 3, 2022
Open Peer Review Period: Oct 3, 2022 - Oct 17, 2022
Date Accepted: Feb 28, 2023
Date Submitted to PubMed: Mar 3, 2023
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Rapid SARS-CoV-2 Antigen Detection Self-Tests to Increase COVID-19 Case Detection in Peru: Qualitative Study

Torres-Slimming PA, Carcamo CP, Martinez-Perez GZ, Mallma P, Plucker-Oses C, Shilton S

Rapid SARS-CoV-2 Antigen Detection Self-Tests to Increase COVID-19 Case Detection in Peru: Qualitative Study

JMIR Form Res 2023;7:e43183

DOI: 10.2196/43183

PMID: 36867689

PMCID: 10027314

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Strategies for the delivery of SARS-COV-2 self-testing: exploring decision maker´s perspectives in Perú

  • Paola A. Torres-Slimming; 
  • Cesar P. Carcamo; 
  • Guillermo Z. Martinez-Perez; 
  • Patricia Mallma; 
  • Cristina Plucker-Oses; 
  • Sonjelle Shilton

ABSTRACT

Background:

Background:

The COVID-19 pandemic heavily impacted many low- and middle-income countries, such as Peru, overwhelming their health systems. Rapid antigen-detection self-tests for SARS-CoV-2, the virus that causes COVID-19, have been proposed as a portable, safe, affordable, and easy-to-perform approach to improve early detection and surveillance of SARS-CoV-2 in resource-constrained populations where there are gaps in access to healthcare.

Methods:

In 2021, a qualitative study was conducted in two areas of Peru (urban Lima and rural Valle del Mantaro), which aimed to explore decision-makers’ values and attitudes toward SARS-CoV-2 self-testing. Purposive sampling was used to identify representatives of various civil society communities, healthcare workers, and potential implementers, to act as informants whose voices would provide a proxy for the public’s attitudes around self-testing. The study received ethics approval from the Universidad Peruana Cayetano Heredia.

Results:

In total, 30 informants participated in individual semi-structured interviews (SSI), and 29 informants participated in five focus group discussions (FGD). Self-tests were considered to represent an approach to increase access to testing that both the rural and urban public in Peru would accept. The public would prefer saliva-based self-tests and would prefer to access them in their community pharmacies. Information about how to perform a self-test should be clear for each population subgroup in Peru. The tests should be of high quality and low cost. Health-informed communication strategies must accompany any introduction of self-testing. Conclusion: The Peruvian public would accept SARS-CoV-2 self-tests if they were accurate, safe to use, easily available, and affordable. Adequate information about the self-tests’ features and instructions, as well as about post-use access to counseling and care, must be made available through Ministry of Health personnel and Peru’s health system channels.

Objective:

With the aim of informing WHO policy guidance and Peru’s public health authorities, a qualitative study was conducted to investigate the public’s values and preferences around self-testing.

Methods:

With the aim of informing WHO policy guidance and Peru’s public health authorities, a qualitative study was conducted to investigate the public’s values and preferences around self-testing.

Results:

This study explored decision-makers’ values and preferences around SARS-CoV-2 self-testing in Peru. Most of the study informants did not know about self-testing; however, they appreciated its advantages and the benefits that it could bring, both to the general public and to the public health system in Peru. The majority of informants expressed a willingness to recommend its use. Regarding preferences, it was suggested that self-testing could be delivered in local pharmacies in coordination with public health services. In the informants’ opinion, if self-test devices had a price of between 5 and 10 USD, the public might find this cost acceptable.

Conclusions:

This study explored decision-makers’ values and preferences around SARS-CoV-2 self-testing in Peru. Most of the study informants did not know about self-testing; however, they appreciated its advantages and the benefits that it could bring, both to the general public and to the public health system in Peru. The majority of informants expressed a willingness to recommend its use. Regarding preferences, it was suggested that self-testing could be delivered in local pharmacies in coordination with public health services. In the informants’ opinion, if self-test devices had a price of between 5 and 10 USD, the public might find this cost acceptable. Clinical Trial: This study received ethical approval from the Institutional Review Board of the Universidad Peruana Cayetano Heredia (ref. 205954).


 Citation

Please cite as:

Torres-Slimming PA, Carcamo CP, Martinez-Perez GZ, Mallma P, Plucker-Oses C, Shilton S

Rapid SARS-CoV-2 Antigen Detection Self-Tests to Increase COVID-19 Case Detection in Peru: Qualitative Study

JMIR Form Res 2023;7:e43183

DOI: 10.2196/43183

PMID: 36867689

PMCID: 10027314

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.